Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 8Unknown 4Recruiting 4Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 4

Conditions

Carcinoma, Non-Small-Cell Lung 1012Lung Neoplasms 769Small Cell Lung Carcinoma 159Breast Neoplasms 73Adenocarcinoma of Lung 68Neoplasms 67Colorectal Neoplasms 50NSCLC 49Melanoma 48Stomach Neoplasms 46Pleural Effusion, Malignant 46Pancreatic Neoplasms 45Brain Neoplasms 42Mesothelioma, Malignant 41Ovarian Neoplasms 32Prostatic Neoplasms 31Neoplasm Metastasis 31Head and Neck Neoplasms 30Mesothelioma 28Esophageal Neoplasms 27Carcinoma, Renal Cell 24Carcinoma 24Urinary Bladder Neoplasms 23Lung Diseases 22Colonic Neoplasms 22Thoracic Neoplasms 19Liver Neoplasms 19Thymoma 18Carcinoma, Hepatocellular 18Pleural Effusion 17

Interventions

tislelizumab 1sugemalimab 1sintilimab 1pembrolizumab 1durvalumab 1camrelizumab 1aumolertinib 1atezolizumab 1Radiotherapy 1Nivolumab 1Immunotherapy 1Cisplatin 1Adjuvants, Immunologic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Radiation Pneumonitis × Thoracic × Clear all
NCT06031597 2023-09-13

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Zhejiang Cancer Hospital

Phase 3 Unknown
105 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Radiation Pneumonitis

NCT02490319 2022-10-07

Study on the Biological Prediction Models of Radiation Pneumonitis

Huazhong University of Science and Technology

Unknown
300 enrolled
Thoracic

Lung Neoplasms, Radiation Pneumonitis

NCT04636593 2021-01-12

A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC

First People's Hospital of Hangzhou

Phase 2 Unknown
43 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiation Pneumonitis

NCT04632342 2020-11-17

Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients

Hanlim Pharm. Co., Ltd.

Phase 2 Unknown
87 enrolled
Thoracic

Lung Neoplasms, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡